There is enormous interest in measuring
amyloid fibril structures,
but most structural studies
measure fibril formation in vitro using aqueous buffer.
Ideally, one would like to measure fibril structure and mechanism
under more physiological conditions. Toward this end, we have developed
a method for studying amyloid fibril structure in human serum. Our
approach uses isotope labeling, antibody depletion of the most abundant
proteins (albumin and IgG), and infrared spectroscopy to measure aggregation
in human serum with reduced protein content. Reducing the nonamyloid
protein content enables the measurements by decreasing background
signals but retains the full composition of salts, sugars, metal ions,
etc. that are naturally present but usually missing from in
vitro studies. We demonstrate the method by measuring the
two-dimensional infrared (2D IR) spectra of isotopically labeled human
islet amyloid polypeptide (hIAPP or amylin). We find that the fibril
structure of hIAPP formed in serum differs from that formed via aggregation
in aqueous buffer at residues Gly24 and Ala25, which reside in the
putative “amyloidogenic core” or FGAIL region of the
sequence. The spectra are consistent with extended parallel stacks
of strands consistent with β-sheet-like structure, rather than
a partially disordered loop that forms in aqueous buffer. These experiments
provide a new method for using infrared spectroscopy to monitor the
structure of proteins under physiological conditions and reveal the
formation of a significantly different polymorph structure in the
most important region of hIAPP.